Chronic obstructive pulmonary diseases (Miami, Fla.)


Publication Venue For

  • Age-dependent associations between 25-hydroxy Vitamin D levels and COPD symptoms: Analysis of SPIROMICS.  8:277-291. 2021
  • InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis of the Western Europe and North America Regions.  8:76-90. 2021
  • Polycythemia is associated with lower incidence of severe COPD exacerbations in the SPIROMICS study.  8:326-335. 2021
  • Thank you all, now onwards and upwards!.  8:303-305. 2021
  • A risk prediction model for mortality among smokers in the COPDGene┬« study.  7:346-361. 2020
  • Immunoglobulin E as a biomarker for the overlap of atopic asthma and chronic obstructive pulmonary disease.  7:1-12. 2020
  • Plasma cathelicidin is independently associated with reduced lung function in COPD: Analysis of the subpopulations and intermediate outcome measures in COPD study cohort.  7:370-381. 2020
  • The association of low income and high stress with acute care use in COPD patients.  7:107-117. 2020
  • COPDGene┬« 2019: Redefining the diagnosis of chronic obstructive pulmonary disease.  6:384-399. 2019
  • Mortality and exacerbations by global initiative for chronic obstructive lung disease groups ABCD: 2011 versus 2017 in the COPDGene┬« cohort.  6:64-73. 2019
  • Physiologic insights from the COPD genetic epidemiology study.  6:256-266. 2019
  • Clinical differences in COPD patients with variable patterns of hypoxemia.  5:167-178. 2018
  • Lung, fat and bone: Increased adiponectin associates with the combination of smoking-related lung disease and osteoporosis.  5:134-143. 2018
  • Race and gender disparities are evident in COPD underdiagnoses across all severities of measured airflow obstruction.  5:177-184. 2018
  • Panlobular Emphysema: Enhancing Visibility with Quantitative Computed Tomography..  3:683-687. 2016
  • COPD Overlap Syndromes: Asthma and Beyond..  3:459-465. 2016
  • Developing and Implementing Biomarkers and Novel Imaging in COPD..  3:485-490. 2016
  • Panlobular Emphysema: Enhancing Visibility with Quantitative Computed Tomography.  3:683-687. 2016
  • Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans..  1:105-114. 2014
  • International Standard Serial Number (issn)

  • 2372-952X
  • Electronic International Standard Serial Number (eissn)

  • 2372-952X